Halpern Financial, Inc. Bristol Myers Squibb CO Transaction History

Halpern Financial, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Sep 21, 2023	SELL	$65.71 - $74.53 $6,570 - $7,453	-100 Reduced 50.0%	100 $6.93 Million
Q2 2022 Sep 21, 2023	SELL	$72.62 - $79.98 $7,262 - $7,998	-100 Reduced 33.33%	200 $15.4 Million
Q3 2021 Sep 21, 2023	SELL	$59.17 - $69.31 $18,993 - $22,248	-321 Reduced 51.69%	300 $17.8 Million
Q2 2021 Sep 21, 2023	BUY	$61.91 - $67.42 $24,764 - $26,968	400 Added 181.0%	621 $41.5 Million
Q1 2021 Sep 21, 2023	BUY	$59.34 - $66.74 $13,114 - $14,749	221 New	221 $14 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Halpern Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Halpern Financial, Inc. with notifications on news.